News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
402,402 Results
Type
Article (12023)
Company Profile (116)
Press Release (390261)
Multimedia
Podcasts (9)
Webinars (3)
Section
Business (124013)
Career Advice (411)
Deals (21580)
Drug Delivery (47)
Drug Development (43600)
Employer Resources (36)
FDA (8701)
Job Trends (10559)
News (199167)
Policy (17117)
Tag
2027 Pharm Country Standard (2)
Academia (1693)
Accelerated approval (20)
Adcomms (7)
Allergies (123)
Alliances (21355)
ALS (113)
Alzheimer's disease (988)
Antibody-drug conjugate (ADC) (229)
Approvals (9076)
Artificial intelligence (308)
Autoimmune disease (130)
Automation (30)
Bankruptcy (147)
Best Places to Work (9401)
BIOSECURE Act (10)
Biosimilars (97)
Biotechnology (48)
Bladder cancer (119)
Brain cancer (37)
Breast cancer (492)
Cancer (3481)
Cardiovascular disease (289)
Career advice (349)
Career pathing (11)
CAR-T (194)
CDC (10)
Cell therapy (486)
Cervical cancer (32)
Clinical research (39537)
Collaboration (1045)
Compensation (500)
Complete response letters (36)
COVID-19 (1271)
CRISPR (64)
C-suite (515)
Cystic fibrosis (88)
Data (4936)
Depression (91)
Diabetes (330)
Diagnostics (4619)
Digital health (26)
Diversity (4)
Diversity, equity & inclusion (11)
Drug discovery (127)
Drug pricing (60)
Drug shortages (8)
Duchenne muscular dystrophy (159)
Earnings (74620)
Editorial (19)
Employer branding (6)
Employer resources (34)
Events (79645)
Executive appointments (621)
FDA (11064)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (4)
Frontotemporal dementia (23)
Funding (907)
Gene editing (140)
Generative AI (17)
Gene therapy (354)
GLP-1 (488)
Government (2588)
Grass and pollen (5)
Guidances (380)
Healthcare (15146)
HIV (41)
Huntington's disease (31)
IgA nephropathy (60)
Immunology and inflammation (146)
Immuno-oncology (46)
Indications (100)
Infectious disease (1443)
Inflammatory bowel disease (142)
Inflation Reduction Act (7)
Influenza (83)
Intellectual property (135)
Interviews (65)
IPO (12687)
IRA (8)
Job creations (1428)
Job search strategy (303)
JPM (17)
Kidney cancer (13)
Labor market (46)
Layoffs (254)
Leadership (8)
Legal (3539)
Liver cancer (53)
Longevity (12)
Lung cancer (484)
Lymphoma (307)
Machine learning (19)
Management (11)
Manufacturing (475)
MASH (115)
Medical device (9923)
Medtech (9965)
Mergers & acquisitions (9749)
Metabolic disorders (763)
mRNA (55)
Multiple sclerosis (113)
NASH (6)
Neurodegenerative disease (203)
Neuropsychiatric disorders (50)
Neuroscience (1860)
Neurotech (1)
NextGen: Class of 2026 (5258)
Non-profit (4252)
Now hiring (26)
Obesity (297)
Opinion (84)
Ovarian cancer (117)
Pain (142)
Pancreatic cancer (161)
Parkinson's disease (223)
Partnered (14)
Patents (258)
Patient recruitment (315)
Peanut (46)
People (28175)
Pharmaceutical (15)
Pharmacy benefit managers (14)
Phase 1 (11726)
Phase 2 (17354)
Phase 3 (14113)
Pipeline (4852)
Policy (77)
Postmarket research (1182)
Preclinical (4084)
Press Release (61)
Prostate cancer (165)
Psychedelics (12)
Radiopharmaceuticals (175)
Rare diseases (575)
Real estate (2785)
Recruiting (16)
Regulatory (13818)
Reports (21)
Research institute (1554)
Resumes & cover letters (74)
Rett syndrome (25)
RNA editing (6)
RSV (42)
Schizophrenia (111)
Series A (157)
Series B (110)
Service/supplier (5)
Sickle cell disease (68)
Special edition (12)
Spinal muscular atrophy (97)
Sponsored (16)
Startups (1346)
State (1)
Stomach cancer (3)
Supply chain (51)
Tariffs (26)
The Weekly (8)
Vaccines (434)
Venture capital (36)
Weight loss (162)
Women's health (64)
Worklife (4)
Date
Today (62)
Last 7 days (348)
Last 30 days (1773)
Last 365 days (20253)
2026 (4367)
2025 (21927)
2024 (22586)
2023 (26923)
2022 (30893)
2021 (34999)
2020 (37341)
2019 (37138)
2018 (27037)
2017 (19874)
2016 (19678)
2015 (23190)
2014 (12766)
2013 (9617)
2012 (10164)
2011 (10407)
2010 (9422)
Location
Africa (298)
Alabama (57)
Alaska (2)
Arizona (184)
Arkansas (7)
Asia (24693)
Australia (3251)
California (8294)
Canada (2050)
China (973)
Colorado (362)
Connecticut (332)
Delaware (280)
Europe (47925)
Florida (1210)
Georgia (285)
Hawaii (1)
Idaho (38)
Illinois (656)
India (59)
Indiana (472)
Iowa (14)
Japan (308)
Kansas (79)
Kentucky (35)
Louisiana (29)
Maine (67)
Maryland (1128)
Massachusetts (5898)
Michigan (216)
Minnesota (481)
Mississippi (6)
Missouri (95)
Montana (30)
Nebraska (16)
Nevada (92)
New Hampshire (67)
New Jersey (2467)
New Mexico (18)
New York (2328)
North Carolina (1112)
North Dakota (4)
Northern California (4195)
Ohio (258)
Oklahoma (17)
Oregon (22)
Pennsylvania (1739)
Puerto Rico (9)
Rhode Island (34)
South America (538)
South Carolina (41)
South Dakota (1)
Southern California (3228)
Tennessee (123)
Texas (1273)
United States (30137)
Utah (279)
Vermont (1)
Virginia (204)
Washington D.C. (51)
Washington State (677)
West Virginia (1)
Wisconsin (71)
402,402 Results for "30".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
C-suite
J&J, AbbVie CEOs See Pay Spike to More Than $30M
The chief executives of AbbVie and Johnson & Johnson are now among the highest-paid pharma leaders after pay bumps pushed their 2025 compensations past $30 million.
March 12, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Bicara Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Business Updates on March 30, 2026, at 8:30 AM ET
March 23, 2026
·
1 min read
Press Releases
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET
March 24, 2026
·
5 min read
Press Releases
RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET
March 20, 2026
·
8 min read
Press Releases
Longeveron Announces Private Placement of up to $30 Million
March 10, 2026
·
8 min read
Press Releases
Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET
March 23, 2026
·
4 min read
Press Releases
Longeveron Announces Closing of Private Placement of up to $30 Million
March 12, 2026
·
8 min read
Press Releases
Inogen Announces $30 Million Share Repurchase Program
February 25, 2026
·
3 min read
Press Releases
Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026
March 19, 2026
·
1 min read
Press Releases
More Than 30 Million Americans Living with Rare Diseases
February 23, 2026
·
4 min read
1 of 40,241
Next
